Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes!

Similar documents
Some Considerations When Designing ADaM Datasets

Introduction to ADaM and What s new in ADaM

What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting

ADaM Implementation Guide Status Update

ADaM IG v1.1 & ADaM OCCDS v1.0. Dr. Silke Hochstaedter

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

Material covered in the Dec 2014 FDA Binding Guidances

Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1

Riepilogo e Spazio Q&A

ADaM Compliance Starts with ADaM Specifications

How to write ADaM specifications like a ninja.

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA

Dealing with changing versions of SDTM and Controlled Terminology (CT)

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania

PharmaSUG Paper PO22

Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA

ADaM for Medical Devices: Extending the Current ADaM Structures

Implementing CDISC Using SAS. Full book available for purchase here.

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania

Deriving Rows in CDISC ADaM BDS Datasets

Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

PharmaSUG2014 Paper DS09

Creating an ADaM Data Set for Correlation Analyses

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

An Efficient Solution to Efficacy ADaM Design and Implementation

Introduction to ADaM standards

Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

NCI/CDISC or User Specified CT

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

Leveraging ADaM Principles to Make Analysis Database and Table Programming More Efficient Andrew L Hulme, PPD, Kansas City, MO

Traceability Look for the source of your analysis results

ADaM Reviewer s Guide Interpretation and Implementation

Optimization of the traceability when applying an ADaM Parallel Conversion Method

Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation

Considerations on creation of SDTM datasets for extended studies

Automate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.

Updates on CDISC Standards Validation

ADaM and traceability: Chiesi experience

Interpreting CDISC ADaM IG through Users Interpretation

PharmaSUG Paper DS24

Common Programming Errors in CDISC Data

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC

Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis

Automated Creation of Submission-Ready Artifacts Silas McKee, Accenture, Pennsylvania, USA Lourdes Devenney, Accenture, Pennsylvania, USA

Applying ADaM Principles in Developing a Response Analysis Dataset

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples

Metadata and ADaM.

Programming checks: Reviewing the overall quality of the deliverables without parallel programming

ADaM Implementation Guide Prepared by the CDISC ADaM Team

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission

DIA 11234: CDER Data Standards Common Issues Document webinar questions

PharmaSUG Paper DS-24. Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP

AZ CDISC Implementation

Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM. Ajay Gupta, PPD

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method

esubmission - Are you really Compliant?

Application of SDTM Trial Design at GSK. 9 th of December 2010

Introduction to Define.xml

Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database

Streamline SDTM Development and QC

Pharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data

Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS

What is high quality study metadata?

Define.xml 2.0: More Functional, More Challenging

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

Study Data Reviewer s Guide Completion Guideline

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

IS03: An Introduction to SDTM Part II. Jennie Mc Guirk

Study Data Reviewer s Guide. FDA/PhUSE Project Summary

Customer oriented CDISC implementation

Why organizations need MDR system to manage clinical metadata?

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

Optimization of the traceability when applying an ADaM Parallel Conversion Method

Traceability: Some Thoughts and Examples for ADaM Needs

From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit

Experience of electronic data submission via Gateway to PMDA

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development

One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc.

Detecting Treatment Emergent Adverse Events (TEAEs)

A Taste of SDTM in Real Time

How to review a CRF - A statistical programmer perspective

Step Up Your ADaM Compliance Game Ramesh Ayyappath & Graham Oakley

CDISC SDTM and ADaM Real World Issues

PhUSE EU Connect 2018 SI05. Define ing the Future. Nicola Perry and Johan Schoeman

CBER STUDY DATA STANDARDS UPDATE

Global Checklist to QC SDTM Lab Data Murali Marneni, PPD, LLC, Morrisville, NC Sekhar Badam, PPD, LLC, Morrisville, NC

SDTM-ETL 4.0 Preview of New Features

PharmaSUG DS05

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008

PharmaSUG Paper PO21

Bay Area CDISC Network: PhUSE Working Group for Inspection Site Selection Data Standards

Robust approach to create Define.xml v2.0. Vineet Jain

Transcription:

1

Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes! The ADaM documentation provides examples of many of the most common analysis situations 85/15 rule NO! How to apply ADaM in every analysis situation is obvious and no thinking is required

When faced with an implementation issue that does not have a documented solution, what is the thought process? How to move forward with developing the best solution? Our panel today is comprised of members of the ADaM Leadership Team and they will share examples of how they have approached implementation issues and reached a compliant solution Then time for your questions! 3

Susan Kenny Sandra Minjoe Nate Freimark Jack Shostak John Troxell Deb Bauer (not present) 4

5

6

What to do when I need a variable other than one specified in the ADaM documents? Examples: In ADSL, I need variable for baseline Karnofsky Performance Status In BDS, I need a variable for the character version of the lab test result, for ease in printing a listing In BDS, I need a variable for a 2 nd baseline In OCCDS, I need a variable to flag AEs that continued past data collection In OCCDS, I am combining AE and CE into one analysis dataset and need a single variable for reporting body system

General Process I follow: 1. Is it legal to include this variable? There are rules describing when variables can be added 2. Does a variable already exist for this concept? Look not only in ADaMIG, but also other standards documents 3. Does a variable fragment exist for any of this concept? Example: if a flag, use suffix FL 4. Consider other conventions when creating a new name 8

Is it legal to include this variable? Does a variable already exist for this concept? Does a fragment exist for any of this concept? Consider other conventions when creating a new name My solution: KPSBL KPS is an industry standard abbreviation for Karnofsky Performance Status BL is an ADaM fragment, and is used as a suffix in ADaMIG examples 9

Is it legal to include this variable? Does a variable already exist for this concept? Does a fragment exist for any of this concept? Consider other conventions when creating a new name My solution: LBSTRESC This variable already exists in SDTM, and I can copy to BDS If I did some imputation and can t use LBSTRESC, another option might be TESTRESL (test result for listing) 10

Is it legal to include this variable? Does a variable already exist for this concept? Does a fragment exist for any of this concept? Consider other conventions when creating a new name My solution: Don t do it! It is not legal to include more than one baseline variable When more than one baseline is needed, that must be done by creating additional rows (alternately another dataset) 11

Is it legal to include this variable? Does a variable already exist for this concept? Does a fragment exist for any of this concept? Consider other conventions when creating a new name My solution: CONTFL CONT is a reasonable abbreviation for continuing FL is the standard fragment for flags 12

Is it legal to include this variable? Does a variable already exist for this concept? Does a fragment exist for any of this concept? Consider other conventions when creating a new name My solution: ABODSYS A is a common ADaM prefix, rather than SDTM s AE or CE BODSYS is the root of both input variables AEBODSYS and CEBODSYS 13

General Process I follow: 1. Is it legal to include this variable? There are rules describing when variables can be added 2. Does a variable already exist for this concept? Look not only in ADaMIG, but also other standards documents 3. Does a variable fragment exist for any of this concept? Example: if a flag, use suffix FL 4. Consider other conventions when creating a new name Use the standards, other documentation, and common sense 14

15

AVAL vs STRESN for analysis ADaM-focused variables vs SDTM-plus Decision have ADaM specific variables AVAL/AVALC PARAM/PARAMCD AVISIT/AVISITN ATPT/ATPTN

Traceability Contrast Listings Variables not covered in ADaMIG

Traceability --SEQ from source SDTM should be included for traceability at a minimum if record comes directly from SDTM Generally for ADaM created from a single SDTM domain SRC* triplets may also sometimes be used ADaMIG states Table 3.3.9.1 defines additional variables useful in certain situations to facilitate data point traceability. VISIT/VISITNUM and ARM might also be useful for traceability

Contrast When date/time imputation are needed it is a good idea to keep the SDTM variable that contains the partial value AVISIT/AVISITN/ATPT/ATPN should be the timing variables that are in datasets VISIT/VISITNUM/--TPT/--TPTNUM should also be kept if the values/algorithms differ Listings Keeping SDTM variables for listing purposes is perfectly fine Variables not covered in ADaMIG --CLSIG --TOX

Referencing SDTM in metadata instead of ADaM variables Creating/Changing SDTM values in ADaM Copying SDTM variables into every ADaM dataset Creating analysis versions of SDTM concepts

Referencing SDTM in metadata instead of ADaM variables ADxx.AVALCAT1/AVALCAT2 should not reference XXSTRESC - it should reference AVALC Creating SDTM values in ADaM VISIT/VISITNUM have to come from SDTM and cannot be derived Copying SDTM variables into every ADaM dataset TCG does mention some SDTM variables to keep in each ADaM but that is a discrete list ARM/ARMCD do not have to be included in every dataset ADaM variables should be used (TRTSEQP) Creating analysis versions of SDTM concepts ARMN- ARM/ARMCD are brought over from SDTM for traceability and not use in analysis. There is no variable ARMGR1 in ADaM ARM is not an analysis variable and therefore there should be no grouping of ARM.

ADAE - Populating AETERM with None for ANYAE=N records is not allowed ADAE - AEDUR is an SDTM variable that is character and IS8601 it cannot be changed to numeric in ADaM it is defined as character in the ADAE appendix correct variable is ADURN ADCM - CMDOSU/CMDOSFRQ/CMROUTE changes from SDTM values this is not allowed ADAE - AESEV you cannot change values from SDTM this includes changing case and label this is supposed to be done in ASEV

24

25

Need a single record per patient dataset that contains data content that is typically (and painstakingly) derived in BDS datasets. For modelling reasons For population determination No appetite for deriving the same thing two times in two different places. Outright hatred for circularity.

Approach #1 ADSL BDS BDS BDS ADXL PROS: Linear process Each derivation in one place CONS: You likely need both ADSL and ADXL for a full true ADSL dataset. BDS datasets that need ADXL content would be created downstream of ADXL creating complexity. OCCDS

Approach #2 ADXL Or ADXLs BDS BDS ADSL PROS: Each derivation in one place Just one ADSL file at the end CONS: Could be multi-path linear, so dependencies can be tricky BDS OCCDS

FDA accepts ADaM IG 1.0. OCCDS finalized January 13, 2015. ADaM IG 1.1 finalized February 12, 2016. Pinnacle follows FDA lead.

Practically, we follow the latest ADaM IG and adapt to the version adoption lag. That means: Using OCCDS, but being forced to dub it as class of ADAM OTHER. Pinnacle checks being behind the times and having to explain away warnings. Also no checks around new variables (e.g., DOSExxP, ASEQ, ASPER). This issue will become more pronounced as we publish IG 1.2 and ADaM v3.

Is ADaM/CDISC always the best idea? Investigator funded research Early phase studies There is no FDA exemption for Phase 1 studies. They carry a similar cost load for CDISC implementation. We consult on these on a case by case basis as to whether to ADaM/CDISC or not. 31

32

33

Analysis Datasets ADaM Datasets Non-ADaM Analysis Datasets ADSL Class Datasets BDS Class Datasets OCCDS Class Datasets OTHER Class Datasets ADSL AD... AD... AD........ 34

ADaM datasets Follow ADaM fundamental principles IMPORTANT in a practical way Follow naming and other conventions ADAM OTHER class datasets are ADaM datasets But do not follow one of the standard structures defined to date Non-ADaM analysis datasets Do not follow ADaM fundamental principles and conventions Non-ADaM analysis dataset is not in the ADAM OTHER class No guidance provided about when it is not acceptable to use ADaM OTHER vs. a standard structure (BDS, OCCDS,...) 35

I really don t like the BDS vertical dataset structure. I prefer a horizontal structure. Can I make a horizontal dataset like I am used to and call it an ADAM OTHER class dataset? ADaMIG has no opinion! But I advise (here is the color part): ADAM OTHER is not a loophole to drive a truck through ADaM is a data standard; we all benefit don t degrade it FDA wants sponsors to use the ADaM data standard Use an ADaM standard structure when a standard structure is capable of enabling the analysis 36

No standard ADaM structure can enable the analysis Use an ADaM OTHER Class dataset for analysis Listing view But don t use for analysis Pre-ADSL dataset Like BDS but without treatment and ADSL variables But don t use for analysis Intermediate dataset; example: EX-plus needed for statistician review; EX + ADSL + derived columns If it follows ADaM fundamental principles etc., can be ADAM OTHER But don t use for analysis; derive a BDS? dataset from it for analysis 37

38